Top Suppliers:I want be here


489402-47-3

489402-47-3 structure
489402-47-3 structure
  • Name: ML213
  • Chemical Name: N-(2,4,6-trimethylphenyl)bicyclo[2.2.1]heptane-3-carboxamide
  • CAS Number: 489402-47-3
  • Molecular Formula: C17H23NO
  • Molecular Weight: 257.371
  • Catalog: Signaling Pathways Membrane Transporter/Ion Channel Potassium Channel
  • Create Date: 2018-12-03 16:37:29
  • Modify Date: 2025-08-20 19:48:42
  • ML213 is a selective activator of Kv7.2 and Kv7.4 channels, enhances Kv7.2 and Kv7.4 channels with EC50s of 230 and 510 nM, respectively.

Name N-(2,4,6-trimethylphenyl)bicyclo[2.2.1]heptane-3-carboxamide
Synonyms Bicyclo[2.2.1]heptane-2-carboxamide, N-(2,4,6-trimethylphenyl)-
N-Mesitylbicyclo[2.2.1]heptane-2-carboxamide
ML-213
CID-3111211
ML213
Description ML213 is a selective activator of Kv7.2 and Kv7.4 channels, enhances Kv7.2 and Kv7.4 channels with EC50s of 230 and 510 nM, respectively.
Related Catalog
Target

EC50: 230 nM (Kv7.2 channel), 510 nM (Kv7.4 channel)[2][3]

In Vitro ML213 (100 nM-30 µM) increases maximal conductance to a peak at 212% ± 27% of control, with an EC50 of 0.8 ± 0.3 µM. ML213 (10 µM) reduces the deactivation rates of Kv7.4 currents by 4.6-fold in the voltage range from −130 mV to −90 mV. ML213 is a potent and effective activator of homomeric Kv7.5 channels overexpressed in A7r5 cells. ML213 increases maximal conductance of Kv7.5 channels with an EC50 of 0.7 ± 0.2 µM. ML213 (10 µM) also reduces deactivation rates of Kv7.5 currents by 5.9-fold on average. ML213 produces similar effects on heteromeric Kv7.4/7.5 channels: 204% ± 11% maximal increase in conductance with an EC50 of 1.1 ± 0.6 µM and a 34.2 ± 3.3 mV maximal negative shift of the activation curve, with an EC50 of 3.8 ± 1.2 µM[1]. ML213 causes a vasorelaxation in different precontracted rat blood vessels. ML213 (10 μM) also hyperpolarizes mesenteric artery smooth muscle cells[2]. ML213 causes a concentration-dependent shift in the V1/2 for KCNQ2 activation with an EC50 340 ± 70 nM and a maximal shift of 37.4 mV[3].
References

[1]. Brueggemann LI, et al. Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673. Mol Pharmacol. 2014 Sep;86(3):330-41.

[2]. Jepps TA, et al. Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370. Br J Pharmacol. 2014 Oct;171(19):4413-24.

[3]. Yu H, et al. Discovery, Synthesis, and Structure Activity Relationship of a Series of N-Aryl- bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener. ACS Chem Neurosci. 2011 Oct 19;2(10):572-577.

Density 1.1±0.1 g/cm3
Boiling Point 398.8±11.0 °C at 760 mmHg
Molecular Formula C17H23NO
Molecular Weight 257.371
Flash Point 243.4±4.2 °C
Exact Mass 257.177979
PSA 32.59000
LogP 4.38
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.591
Storage condition 2-8℃
Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H315-H319-H335-H413
Precautionary Statements P261-P305 + P351 + P338
RIDADR NONH for all modes of transport
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.